Genomics

Dataset Information

0

Methylome sequencing of cell-free DNA and RRBS of solid tissue


ABSTRACT: Early cancer detection by cell-free DNA (cfDNA) faces multiple challenges: low fraction of tumor cfDNA, molecular heterogeneity of cancer, and sample sizes not sufficient to reflect diverse patient population. We develop a cancer detection approach to address these challenges. It consists of an assay, cfMethyl-Seq, for cost-effective sequencing of cfDNA methylome (with >12-fold enrichment over whole genome bisulfite sequencing in CpG islands), and a computational method to extract methylation information and diagnose patients. Applying our system to 408 colon, liver, lung, and stomach cancer patients and controls, at 97.9% specificity we achieve 80.7% and 74.5% sensitivity in detecting all-stage and early-stage cancer, and 89.1% and 85.0% accuracy for locating tissue-of-origin of all-stage and early-stage cancer, respectively. Our approach cost-effectively retains methylome profiles of cancer abnormalities, thereby permitting the classification models to learn new features as training cohorts grow, and expanding their scope to other cancer types.

PROVIDER: EGAS00001006020 | EGA |

REPOSITORIES: EGA

Similar Datasets

2019-03-31 | E-MTAB-7163 | biostudies-arrayexpress
2022-01-07 | GSE124775 | GEO
2024-09-02 | BIOMD0000000741 | BioModels
2022-05-13 | GSE202606 | GEO
2022-07-21 | GSE208596 | GEO
| EGAS00001007192 | EGA
2023-11-06 | MSV000093325 | MassIVE
2019-08-07 | GSE112679 | GEO
2022-11-16 | GSE214344 | GEO
2022-09-14 | E-MTAB-11607 | biostudies-arrayexpress